选择美洛昔康治疗类风湿性关节炎临床疗效观察

摘要

目的：分析美洛昔康辅助治疗类风湿的临床疗效，给临床的类风湿的药物内科治疗提供新的用药思维方法搜集在我院进行诊疗的100例类风湿患者，然后根据随机分组的方法将所抽取的患者平均分为实验组和对照组。结果实验组患者的总有效率高于对照组，（P＜0.05）差异具有统计学意义。结论常规应用药物联合美洛昔康辅助性治疗，可有效的提高类风湿的症状缓解率并且获得不错的临床诊疗效果，值得在临床一线应用上进行推广借鉴。%ObjectiveThe clinical efifcacy of meloxicam adjuvant treatment of rheumatoid to clinical medical treatment for rheumatoid drugs offer new medication thinking.Methods Collected in our hospital for treatment of 100 cases of rheumatoid patients, and in accordance with the method of the patients randomized to extract an average score of the experimental group and the control group.Results The results of the experimental group were significantly better total efficiency of the control group, (P<0.05) differences were statistically signiifcant.Conclusions Routine use of drugs in the United meloxicam adjuvant treatment, symptoms can effectively improve the rate of rheumatoid get a good clinical and clinical results, it is worth to promote learning in the clinical front-line applications.